Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Intravitreal clindamycin and dexamethasone for the treatment of ocular toxoplasmosis in a pregnant woman

Poster Details

First Author: B.Stoica SPAIN

Co Author(s):    E. Corredera Salinero   I. Gabarron Hermosilla   N. Toledano Fernandez        

Abstract Details


To present a case of ocular toxoplasmosis in a pregnant woman successfully treated with three injections of intravitreal clindamycin and dexamethasone. We evaluate the advantages over systemic treatment.


Hospital Universitario de Fuenlabrada


A 36 year-old patient, 3 months pregnant, presents to the emergency room with decreased visual acuity, red eye and photophobia. The eye exam revealed significant anterior uveitis, normal intraocular pressure, significant vitritis and a chorioretinal focus outside the arcades (" headlight in the fog" ). She was treated with 3 intravitreal injections of clindamycin (1 mg in 0.1 ml) and dexamethasone (400microg in 0.1 ml), 1 injection every 2 weeks. Topical dexamethasone and cycloplegic eye drops were used for the anterior uveitis.


The patient had a significant visual improvement 3 days after the first injection, continued to improve with the next injections, reaching a final visual acuity of 0.7, which she maintains in the present. The vitritis disappeared and the chorioretinal focus decreased, leaving only a pigmented scar.


Ocular toxoplasmosis is the most common cause of infectious posterior uveitis and can cause significant visual loss. For the classical ocular involvement we recommend the intravitreal injections rather than administering a systemic antibiotic therapy. Treatment with two or three injections has many advantages compared to the classic therapy with 10 pills a day: better compliance, availability, fewer visits, no systemic side effects (blood disorders, pregnant women, children). FINANCIAL DISCLOSURE?: No

Back to previous

loading Please wait while information is loading.